# Commission Decision of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under document number C(2002) 1344) (Text with EEA relevance) (2002/364/EC), Division 3.3.2a

Extent: E+W+S+N.I.

Qualitative HIV NAT assays intended to be used to detect the presence of HIV in blood, blood components, cells, tissues or organs, or in any of their derivatives, in order to assess their suitability for transfusion, transplantation or cell administration shall be designed to detect both HIV-1 and HIV-2.

---
Source: https://www.legislation.gov.uk/eudn/2002/364/annex/division/3/division/3.3/division/3.3.2a (the official version)
Page: https://openlegislation.uk/eu-decision-2002-364/annex/division-3/division-3.3/division-3.3.2a
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

